Johnson & Johnson expands ophthalmologic market in China

Wang Liping, general manager of J&J Surgical Vision in China [Photo/Qianjiang Evening News]

Talking about settling in Hangzhou, Wang Liping, general manager of J&J Surgical Vision in China, hailed the city as open and diversified.

"Hangzhou is at the forefront of innovation and entrepreneurship, as represented by Chinese e-commerce giant Alibaba Group," he said, adding that the local government has also created a favorable business environment for foreign-funded companies and issued a series of preferential policies to attract international talents.

Wang said he believes that the diversified population structure in China means increased demand for health care, and the country's growing competitiveness in hi-tech industries, including artificial intelligence, cloud computing and big data, will boost the transformation and development of the health care industries.

"We place a high value on the Chinese market and will continue to push forward economic and trade cooperation and exchanges between China and the US as well as other countries across the globe," he said.

With a focus on attracting foreign businesses and investment, HEDA has lured over 780 foreign-funded enterprises from 50 countries and regions. Hangzhou Biopharma Town, an industrial cluster for biopharmaceutical development in HEDA, has attracted more than 300 companies and research institutes in the biopharmaceutical sector with total output reaching 25 billion yuan ($3.6 billion).